The relationship between sarcopenia and serum irisin and TNF-[alpha] levels in newly diagnosed cancer patients

Objective Sarcopenia in patients with cancer makes patients physically weak and adversely affects their compliance with treatment. In this study, we investigated the relationship between sarcopenia in patients with cancer and circulating irisin and tumor necrosis factor-alpha (TNF-[alpha]) levels. M...

Full description

Saved in:
Bibliographic Details
Published in:Supportive care in cancer 2023-10, Vol.31 (10)
Main Authors: Demir, Leyla, Oflazoglu, Utku
Format: Article
Language:English
Subjects:
Cancer
Cancer patients
Enzyme-linked immunosorbent assay
Enzymes
Muscles
Oncology, Experimental
Physiological aspects
Sarcopenia
Tumor necrosis factor
Type 2 diabetes
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Sarcopenia in patients with cancer makes patients physically weak and adversely affects their compliance with treatment. In this study, we investigated the relationship between sarcopenia in patients with cancer and circulating irisin and tumor necrosis factor-alpha (TNF-[alpha]) levels. Material and method A total of 141 patients with different types of newly diagnosed cancer were divided into two groups, sarcopenia (n = 72) and non-sarcopenia (n = 69) groups. The body compositions of the patients were measured using bioelectrical impedance (BIA) and muscle strength using hand grip strength (HGS) tests. Serum irisin and TNF-[alpha] levels were measured using an enzyme-linked immunosorbent assay. Results In our study, serum irisin levels were found to be significantly lower (p < 0.01) and TNF-[alpha] levels were found to be significantly higher (p = 0.014) in the sarcopenia group. Skeletal muscle index (SMI) and HGS values and serum irisin levels were positively correlated [(r: 0.451, p < 0.001), (r: 0.469, p < 0.001)], and SMI and HGS values and serum TNF-[alpha] levels were negatively correlated [(r: -0.181, p = 0.032) and (r: -0.143, p = 0.090), respectively]. In addition, multiple linear regression analysis showed that serum irisin and TNF-[alpha] levels were independent predictors of sarcopenia. Conclusion Serum irisin levels were found to be significantly lower in patients with cancer with sarcopenia, and TNF-[alpha] levels were found to be significantly higher. These two markers can be used as potential biomarkers for the diagnosis of sarcopenia in patients with cancer. The efficacy and possible mechanisms of action of irisin and TNF-[alpha] in the diagnosis of sarcopenia should be investigated with larger patient groups.
ISSN:0941-4355
DOI:10.1007/s00520-023-08041-6